248 related articles for article (PubMed ID: 11872380)
1. The pathophysiologic basis of efficacy and clinical experience with the new oral antidiabetic agents.
Rosak C
J Diabetes Complications; 2002; 16(1):123-32. PubMed ID: 11872380
[TBL] [Abstract][Full Text] [Related]
2. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
3. Sulfonylurea treatment of type 2 diabetes mellitus: focus on glimepiride.
Korytkowski MT
Pharmacotherapy; 2004 May; 24(5):606-20. PubMed ID: 15162895
[TBL] [Abstract][Full Text] [Related]
4. Oral antidiabetic drugs: an overview.
Melander A
Diabet Med; 1996 Sep; 13(9 Suppl 6):S143-7. PubMed ID: 8894498
[TBL] [Abstract][Full Text] [Related]
5. Treatment of type 2 diabetes mellitus: pharmacologic intervention.
McCormick M; Quinn L
J Cardiovasc Nurs; 2002 Jan; 16(2):55-67. PubMed ID: 11800068
[TBL] [Abstract][Full Text] [Related]
6. Effects of current therapeutic interventions on insulin resistance.
Kobayashi M
Diabetes Obes Metab; 1999 May; 1 Suppl 1():S32-40. PubMed ID: 11220286
[TBL] [Abstract][Full Text] [Related]
7. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Clark HE; Matthews DR
Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
[TBL] [Abstract][Full Text] [Related]
8. Glucose-dependent and glucose-sensitizing insulinotropic effect of nateglinide: comparison to sulfonylureas and repaglinide.
Hu S; Wang S; Dunning BE
Int J Exp Diabetes Res; 2001; 2(1):63-72. PubMed ID: 12369728
[TBL] [Abstract][Full Text] [Related]
9. Oral hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers.
Raptis SA; Dimitriadis GD
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S265-87. PubMed ID: 11460577
[TBL] [Abstract][Full Text] [Related]
10. Type II diabetes mellitus.
Edelman SV
Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
[TBL] [Abstract][Full Text] [Related]
11. [Repaglinide in combination therapy in type 2 diabetes].
Moses R
Diabetes Metab; 1999 Dec; 25 Suppl 7():26-7. PubMed ID: 10746009
[TBL] [Abstract][Full Text] [Related]
12. New directions in type 2 diabetes mellitus: an update of current oral antidiabetic therapy.
Brown DL; Brillon D
J Natl Med Assoc; 1999 Jul; 91(7):389-95. PubMed ID: 10643211
[TBL] [Abstract][Full Text] [Related]
13. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
Harrigan RA; Nathan MS; Beattie P
Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy of type 2 diabetes mellitus.
Rendell MS; Kirchain WR
Ann Pharmacother; 2000; 34(7-8):878-95. PubMed ID: 10928401
[TBL] [Abstract][Full Text] [Related]
15. [Present status in the treatment of type 2 diabetes mellitus. Insulin-secreting agents].
Blicklé JF; Andres E; Neyrolles N; Brogard JM
Rev Med Interne; 1999 Aug; 20 Suppl 3():351s-359s. PubMed ID: 10480186
[TBL] [Abstract][Full Text] [Related]
16. Rationale for and role of thiazolidinediones in type 2 diabetes mellitus.
Lebovitz HE
Am J Cardiol; 2002 Sep; 90(5A):34G-41G. PubMed ID: 12231077
[TBL] [Abstract][Full Text] [Related]
17. [Drug treatment of type 2 diabetes].
Tielmans A; Laloi-Michelin M; Coupaye M; Virally M; Meas T; Guillausseau PJ
Presse Med; 2007 Feb; 36(2 Pt 2):269-78. PubMed ID: 17258675
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
Kitaoka H
Nihon Rinsho; 2002 Sep; 60 Suppl 9():464-9. PubMed ID: 12387035
[No Abstract] [Full Text] [Related]
19. Insulin secretagogues.
Davies MJ
Curr Med Res Opin; 2002; 18 Suppl 1():s22-30. PubMed ID: 12365816
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of type 2 diabetes: rationale for different oral antidiabetic treatment strategies.
Giorgino F; Laviola L; Leonardini A
Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S22-9. PubMed ID: 15955371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]